`nature communications, Peer-reviewed journal

New York, Sep 18 People infected with the original strain of the SARS-CoV2 virus that caused Covid-19 early during the pandemic outbreak produced a consistent antibody response, making two main groups of antibodies to bind to the spike protein on the virus's outer surface.However, those antibodies don't bind well to newer variants, finds a new study, published in the journal Nature Communications.According to researcher Nicholas Wu from the University of Illinois at Urbana-Champaign, characterising what kinds of antibodies the body is most likely to make to fight a natural infection is an important roadmap for vaccine design.For the study, the researchers mined published papers about Covid-19 patients for data about the sequence of the antibodies they produced.They focused on antibodies against the spike protein, the part of the virus that binds to receptors on human cells to infect them. The spike protein is the target of most vaccines.They found that many antibody sequences converged into two main groups, indicating a consistent human immune response to the virus."We really focused on characterising the antibodies created in those infected with the original strain of the virus," said Timothy Tan, a graduate student part of the research."Before we started the study, variants weren't much of a problem. As they emerged, we wanted to see whether the common antibodies we identified were able to bind to newer variants," Tan added.The researchers studied the convergent antibodies' ability to bind to several variants and found that they no longer bound to some.The finding has implications for the ability of new variants to reinfect people who contracted earlier versions of the virus, as well as for the continuing efficacy of vaccines and the design of possible vaccine boosters."Even though this antibody response is very common with the original strain, it doesn't really interact with variants," Wu said."That, of course, raises the concern of the virus evolving to escape the body's main antibody response. Some antibodies should still be effective the body makes antibodies to many parts of the virus, not only the spike protein but the particular groups of antibodies that we saw in this study will not be as effective," Wu added.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

`nature CommunicationsFOLLOW

`nature communications, Latest News

Generally when DNA is visualized, it's a string-like double helix structure which is thought of, however, the reality is that DNA double helix in cells is supercoiled and constrained into loops. Every aspect of DNA activity is known to be influenced ...

The findings of a recent study suggest that micro-organism resistance to antibiotics, in particular, is a major problem in everyday medicine because this has led to an exponential increase in the number of resistant microbes. ...

The findings of a new study show that a computer programme trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer. ...

During a recent study, Hiroshima University researchers analysed the molecular findings of almost 160 pediatric liver cancer cases which led to the discovery of molecular markers that would help to understand and treat the considerable variation in p ...

Researchers at the University of Liverpool have shown how SARS-CoV-2 viral proteases attack the host cell, and how this can be targeted to stop virus replication in cell culture using existing drugs. ...

Micro-organism resistance to antibiotics, in particular, is a major problem in everyday medicine. This has seen the number of resistant microbes increase exponentially. ...

Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the treatment of a broad spectrum of brain disorders. ...

New York, Sep 18 People infected with the original strain of the SARS-CoV2 virus that caused Covid-19 early ... ...